These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26758404)

  • 21. Incidence, risk factors, microbiology of venous catheter associated bloodstream infections--a prospective study from a tertiary care hospital.
    Kaur M; Gupta V; Gombar S; Chander J; Sahoo T
    Indian J Med Microbiol; 2015; 33(2):248-54. PubMed ID: 25865976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of central venous catheter insertion and care bundles in a high central line-associated bloodstream infection rate, high bed occupancy hospital.
    Karapanou A; Vieru AM; Sampanis MA; Pantazatou A; Deliolanis I; Daikos GL; Samarkos M
    Am J Infect Control; 2020 Jul; 48(7):770-776. PubMed ID: 31911066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of tailored interventions in a statewide programme to reduce central line-associated bloodstream infections.
    Assis DB; Madalosso G; Padoveze MC; Lobo RD; Oliveira MS; Boszczowski Í; Singer JM; Levin AS
    J Hosp Infect; 2018 Nov; 100(3):e163-e168. PubMed ID: 29730142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
    Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
    Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.
    Buetti N; Ruckly S; Lucet JC; Mimoz O; Souweine B; Timsit JF
    Intensive Care Med; 2019 Dec; 45(12):1774-1782. PubMed ID: 31624854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of infection control training for interns on PICU-acquired bloodstream infections in a middle-income country.
    Ng YY; Abdel-Latif Mel-A; Gan CS; Siham A; Zainol H; Lum LC
    Singapore Med J; 2015 Sep; 56(9):506-12. PubMed ID: 26451053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Deficits in central venous catheter associated bloodstream infection].
    Hansen S; Schwab F; Schneider S; Sohr D; Gastmeier P; Geffers C
    Dtsch Med Wochenschr; 2013 Aug; 138(34-35):1711-6. PubMed ID: 23934589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of clinical practice guidelines on the incidence of bloodstream infections related to peripherally inserted central venous catheter in preterm infants].
    Boutaric E; Gilardi M; Cécile W; Fléchelles O
    Arch Pediatr; 2013 Feb; 20(2):130-6. PubMed ID: 23245862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital-wide multidisciplinary, multimodal intervention programme to reduce central venous catheter-associated bloodstream infection.
    Zingg W; Cartier V; Inan C; Touveneau S; Theriault M; Gayet-Ageron A; Clergue F; Pittet D; Walder B
    PLoS One; 2014; 9(4):e93898. PubMed ID: 24714418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for central venous catheter-related bloodstream infections.
    Bekçibaşi M; Dayan S; Aslan E; Kortak MZ; Hoşoğlu S
    Infez Med; 2019 Sep; 27(3):258-265. PubMed ID: 31545769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a multimodal intervention to reduce bloodstream infections related to vascular catheters in non-ICU wards: a multicentre study.
    Freixas N; Bella F; Limón E; Pujol M; Almirante B; Gudiol F
    Clin Microbiol Infect; 2013 Sep; 19(9):838-44. PubMed ID: 23130638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.
    Maki DG; Kluger DM; Crnich CJ
    Mayo Clin Proc; 2006 Sep; 81(9):1159-71. PubMed ID: 16970212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlorhexidine disinfectant can reduce the risk of central venous catheter infection compared with povidone: a meta-analysis.
    Shi Y; Yang N; Zhang L; Zhang M; Pei HH; Wang H
    Am J Infect Control; 2019 Oct; 47(10):1255-1262. PubMed ID: 30948152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of Central Venous Catheter-Related Bloodstream Infections: Evaluation of Bundle Prevention in Two Intensive Care Units in Central Brazil.
    Yoshida T; Silva AEBC; Simões LLP; Guimarães RA
    ScientificWorldJournal; 2019; 2019():1025032. PubMed ID: 31687000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
    Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
    J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.
    Brunelli SM; Van Wyck DB; Njord L; Ziebol RJ; Lynch LE; Killion DP
    J Am Soc Nephrol; 2018 Apr; 29(4):1336-1343. PubMed ID: 29472415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
    Ohtake S; Takahashi H; Nakagawa M; Uchino Y; Miura K; Iriyama N; Nakayama T; Hatta Y; Takei M
    J Infect Chemother; 2018 Jul; 24(7):544-548. PubMed ID: 29627326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years.
    Eggimann P; Pagani JL; Dupuis-Lozeron E; Ms BE; Thévenin MJ; Joseph C; Revelly JP; Que YA
    Intensive Care Med; 2019 Jun; 45(6):823-833. PubMed ID: 30997542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.